Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C, Suárez-González J, Rodríguez-Macías G, Dorado N, Osorio S, Font P, Carbonell D, Chicano M, Muñiz P, Bastos M, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C.
Andrés-Zayas C, et al.
Mol Oncol. 2021 Sep;15(9):2273-2284. doi: 10.1002/1878-0261.12921. Epub 2021 Jul 16.
Mol Oncol. 2021.
PMID: 33533142
Free PMC article.